Loading…
Operates skilled nursing and post-acute care facilities across several US states.
Operates skilled nursing and post-acute care facilities across several US states.
Is paid mainly by government programmes, Medicare for short rehabilitation stays and Medicaid for longer stays, plus private insurers, at rates set per patient day, so reimbursement policy matters as much as occupancy. Growth has come from taking over underperforming facilities and improving them, many of them leased rather than owned. It went public in 2024.
Moat: narrow (scale, regulatory licence). State licensing and facility-acquisition scale give regional density versus smaller nursing-home operators.
Headquarters: Farmington, Utah, US · Founded: 2013 · Employees: 47,455
Size PACS (PACS) is a United States Health Care company (Hospital/Nursing Management) with a market value of $7.87B, the 898th largest of 3,117 United States companies the cockpit tracks. Shares closed at $49.60 on 6 Nov 2026.
Performance Over six months the shares gained 47.7%, against +9.2% for the median peer and -1.1% for the United States market (cap-weighted) — 5th highest of 17 in its peer set.
Growth Revenue grew 11.0% over the last twelve months (peer median +8.0%); the operating margin is 7.5% (peer median 13.6%).
Valuation It trades at 19.2× forward earnings against a peer median of 47.2× (4th cheapest of 17).
Price implies For today's price to make sense, revenue must grow about 8% a year for seven years (Req g). Recent delivered growth is +30%, so the hurdle is -22 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 1.4 points above its cost of capital (6.1% WACC).
Short interest Short interest is 2.7% of the free float (15 Oct 2026).
Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $5.71B | $5.29B | $4.09B | $3.11B | $2.42B |
| Revenue growth | — | +29% | +31% | +28% | — |
| Gross profit | $902M | $725M | $467M | $421M | $378M |
| EBITDA | $503M | $366M | $166M | $277M | $252M |
| Net income | $278M | $192M | $55.8M | $113M | $150M |
| Free cash flow | $448M | $299M | $301M | $17.9M | $69.8M |
| Capital expenditure | $132M | $105M | $66.5M | $45.8M | $22.9M |
| Total debt | $3.44B | $3.60B | $3.63B | $2.85B | $1.93B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| PACS PACS | $7.87B | +48% | +11% | 8% | 19.2× | 7.6% |
| Ensign ENSG | $10.6B | +6% | +17% | 9% | 21.1× | 12.0% |
| Brookdale Senior Living BKD | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% |
| National HealthCare NHC | $3.27B | +11% | +7% | -8% | n/a | 7.9% |
| Pennant PNTG | $1.27B | +1% | +38% | 6% | 24.0× | 21.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PACS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +13.4% | +6.0% | 3rd highest of 18 |
| 6-month return | +47.7% | +9.2% | 5th highest of 17 |
| Distance from 52-week high | -4.0% | -15.7% | 4th highest of 18 |
| Revenue growth (TTM) | +11.0% | +8.0% | 9th highest of 18 |
| Operating margin | 7.5% | 13.6% | 5th lowest of 18 |
| Forward P/E | 19.2× | 47.2× | 4th cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | 7.6% | 14.3% | 5th least demanding of 16 |
| Growth delivered (Del g) | +29.7% | +8.7% | highest of 16 |
| Hurdle (Req g minus delivered) | -22.1 pp | +6.0 pp | least demanding of 16 |
| ROIC minus cost of capital | +1.4 pp | -1.1 pp | 8th highest of 18 |
| EV / EBITDA | 22.3× | 22.1× | 8th most expensive of 16 |
| Net debt / EBITDA | 6.6× | 2.2× | 2nd most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| PACS PACS | United States | $7.87B | +48% | +11% | 8% | 19.2× | 7.6% | +29.7% |
| Ramsay Health Care RHC.AX | Australia | $8.87B | +52% | +4% | 5% | 32.4× | 14.3% | +8.3% |
| Manipal Health Enterprises MANIPALHOS.NS | India | $9.01B | n/a | +25% | 19% | 63.1× | 29.7% | +28.8% |
| Chemed CHE | United States | $6.87B | +24% | +5% | 14% | 19.5× | 2.4% | +4.0% |
| Aster DM Quality Care ASTERDM.NS | India | $6.57B | -3% | +16% | 14% | 49.6× | 55.3% | -11.6% |
| Max Healthcare Institute MAXHEALTH.NS | India | $9.61B | -8% | +15% | 21% | 49.7× | 43.2% | +27.2% |
| Fortis Healthcare FORTIS.NS | India | $6.13B | -19% | +18% | 17% | 45.0× | 41.0% | +17.9% |
| Universal Health Services UHS | United States | $11.5B | +15% | +8% | 11% | 8.7× | -1.2% | +8.5% |
| Apollo Hospitals Enterprise APOLLOHOSP.NS | India | $12.8B | +8% | +19% | 12% | 49.3× | 32.2% | +19.0% |
| Narayana Hrudayalaya NH.NS | India | $4.11B | +3% | +71% | 13% | 36.5× | 31.1% | +25.0% |
| Global Health MEDANTA.NS | India | $3.95B | +15% | +26% | 17% | 51.1× | n/a | n/a |
| National HealthCare NHC | United States | $3.27B | +11% | +7% | -8% | n/a | 7.9% | +9.7% |
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.21B | +2% | +31% | 12% | 70.0× | n/a | n/a |
| Surgery Partners SGRY | United States | $2.99B | +61% | +4% | 14% | 62.5× | 13.8% | +12.2% |
| Tenet Healthcare THC | United States | $22.5B | +49% | +6% | 17% | 14.0× | -1.2% | +3.9% |
| Topchoice Medical 600763.SS | China | $2.51B | -11% | +7% | 26% | 26.7× | 13.6% | +6.9% |
| Ardent Health ARDT | United States | $2.44B | +71% | +3% | 4% | 14.5× | 4.0% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% | -1.4% |